Anastasia Antoniou1, Nikolas Evripidou1, Stelios Panayiotou2, Kyriakos Spanoudes1, Christakis Damianou3. 1. Department of Electrical Engineering, Computer Engineering, and Informatics, Cyprus University of Technology, 30 Archbishop Kyprianou Street, 3036, Limassol, Cyprus. 2. SGS Diagnostic Centre of Histopathology and Cytology Limited, 21 Thessalonikis, 3025, Limassol, Cyprus. 3. Department of Electrical Engineering, Computer Engineering, and Informatics, Cyprus University of Technology, 30 Archbishop Kyprianou Street, 3036, Limassol, Cyprus. christakis.damianou@cut.ac.cy.
Abstract
PURPOSE: In recent years, veterinary medicine has enhanced its applications beyond traditional approaches, progressively incorporating the Focused Ultrasound (FUS) technology. This study investigated the ability of FUS to precisely ablate naturally occurring canine and feline soft tissue sarcomas (STS). METHODS: Six dogs and four cats with superficial tumours were enrolled in the study. The tumours were treated with a Magnetic Resonance guided FUS (MRgFUS) robotic system featuring a single element spherically focused transducer of 2.6 MHz. The tumours were then removed by surgery and sent for hematoxylin and eosin (H&E) staining. RESULTS: The MRgFUS system was capable of inflicting well-defined overlapping lesions in the tumours. The anatomical sites of the treated tumours were the neck, leg, face, back and belly. Coagulative necrosis was evidenced by histopathology assessment in 80% of cases. CONCLUSION: Therefore, this technology can be a therapeutic solution for veterinary cancer and a model for advancing the knowledge on human STS.
PURPOSE: In recent years, veterinary medicine has enhanced its applications beyond traditional approaches, progressively incorporating the Focused Ultrasound (FUS) technology. This study investigated the ability of FUS to precisely ablate naturally occurring canine and feline soft tissue sarcomas (STS). METHODS: Six dogs and four cats with superficial tumours were enrolled in the study. The tumours were treated with a Magnetic Resonance guided FUS (MRgFUS) robotic system featuring a single element spherically focused transducer of 2.6 MHz. The tumours were then removed by surgery and sent for hematoxylin and eosin (H&E) staining. RESULTS: The MRgFUS system was capable of inflicting well-defined overlapping lesions in the tumours. The anatomical sites of the treated tumours were the neck, leg, face, back and belly. Coagulative necrosis was evidenced by histopathology assessment in 80% of cases. CONCLUSION: Therefore, this technology can be a therapeutic solution for veterinary cancer and a model for advancing the knowledge on human STS.
Authors: Milan Milovancev; Katy L Townsend; Joanne L Tuohy; Elena Gorman; Shay Bracha; Kaitlin M Curran; Duncan S Russell Journal: Vet Surg Date: 2019-05-02 Impact factor: 1.495
Authors: Ann E Hohenhaus; Jennifer L Kelsey; Jamie Haddad; Lisa Barber; Matthew Palmisano; John Farrelly; Anita Soucy Journal: J Am Anim Hosp Assoc Date: 2016-01-25 Impact factor: 1.023